The United States is a notable market for refractive surgery; nearly 20 percent of global laser vision correction (LVC) takes place in the US annually. Of the more than 329 million people in the US, over half require some vision correction. Demand for refractive procedures is driven largely by the country’s millennial population and a subset of relatively affluent and healthy individuals. Market Scope has developed the 2018 United States Refractive Atlas to analyze the opportunity in the top 75 metropolitan areas, with an 10 additional honorable mentions.
Featured in the atlas is Market Scope's proprietary Med/Op Index™, which estimate the opportunities for refractive surgery in each metropolitan area. This index identifies the potential based on a variety of factors including population age distribution, education level, income/buying power, overall health statistics, and population density.
A corporate accounts gives you access to licensed reports and subscriptions, the latest news, and a personalized dashboard.